{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:38:58Z","timestamp":1782477538486,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.atherosclerosis.2009.03.029","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T04:23:44Z","timestamp":1238991824000},"page":"535-539","source":"Crossref","is-referenced-by-count":107,"title":["Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)"],"prefix":"10.1016","volume":"206","author":[{"given":"Shinichi","family":"Oikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Origasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masunori","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Matsuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Hishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Itakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kitabatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiie","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Shirato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)","volume":"316","author":"Turner","year":"1998","journal-title":"British Medical Journal"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diacare.20.4.614","article-title":"Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)","volume":"20","author":"Pyorala","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib3","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.CIR.98.23.2513","article-title":"Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial","volume":"98","author":"Goldberg","year":"1998","journal-title":"The Care Investigators, Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib4","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/diacare.26.10.2713","article-title":"Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial","volume":"26","author":"Keech","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib5","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0002-9149(01)01464-3","article-title":"Air Force\/Texas Coronary Atherosclerosis Prevention Study (AFCAPS\/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin","volume":"87","author":"Downs","year":"2001","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2006.04.017","article-title":"Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT)","volume":"191","author":"Oikawa","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1253\/circj.66.1087","article-title":"Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia","volume":"66","author":"Matsuzaki","year":"2002","journal-title":"Circulation Journal"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib8","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1253\/circj.66.1096","article-title":"Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT)","volume":"66","author":"Mabuchi","year":"2002","journal-title":"Circulation Journal"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib9","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.0000055315.79177.16","article-title":"Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study","volume":"107","author":"Mozaffarian","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.287.14.1815","article-title":"Fish and omega-3 fatty acid intake and risk of coronary heart disease in women","volume":"287","author":"Hu","year":"2002","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib11","doi-asserted-by":"crossref","unstructured":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto miocardico. Lancet 1999;354:447\u201355.","DOI":"10.1016\/S0140-6736(99)07072-5"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCULATIONAHA.105.581355","article-title":"Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I","volume":"113","author":"Iso","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib13","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-8703(03)00367-3","article-title":"Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS)","volume":"146","author":"Yokoyama","year":"2003","journal-title":"American Heart Journal"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib15","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.241.19.2035","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"Journal of the American Medical Association"},{"issue":"Suppl 3","key":"10.1016\/j.atherosclerosis.2009.03.029_bib16","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/diab.45.3.S14","article-title":"Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study","volume":"45","author":"Fujishima","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.atherosclerosis.2006.03.005","article-title":"Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes","volume":"191","author":"Mita","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2337\/dc06-1179","article-title":"Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome","volume":"30","author":"Satoh","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib19","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/0006-2952(84)90611-7","article-title":"Effect of orally administered eicosapentaenoic acid (EPA) on the formation of leukotriene B4 and leukotriene B5 by rat leukocytes","volume":"33","author":"Terano","year":"1984","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0049-3848(82)90112-8","article-title":"The effects of the oral administration of fish oil concentrate on the release and the metabolism of [14C]arachidonic acid and [14C]eicosapentaenoic acid by human platelets","volume":"28","author":"Hirai","year":"1982","journal-title":"Thrombosis Research"},{"issue":"Suppl","key":"10.1016\/j.atherosclerosis.2009.03.029_bib21","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1007\/BF02637096","article-title":"Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals","volume":"31","author":"Terano","year":"1996","journal-title":"Lipids"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(03)12468-3","article-title":"Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial","volume":"361","author":"Thies","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5551\/jat.9.170","article-title":"Changes in aspects such as the collagenous fiber density and foam cell size of atherosclerotic lesions composed of foam cells, smooth muscle cells and fibrous components in rabbits caused by all-cis-5, 8, 11, 14, 17-icosapentaenoic acid","volume":"9","author":"Kawano","year":"2002","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.hep.2003.09.028","article-title":"Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression","volume":"38","author":"Sekiya","year":"2003","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib26","doi-asserted-by":"crossref","first-page":"35840","DOI":"10.1074\/jbc.274.50.35840","article-title":"A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids","volume":"274","author":"Yahagi","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib27","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2337\/dc06-1332","article-title":"n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data","volume":"30","author":"De Caterina","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2009.03.029_bib28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/0006-2952(96)00473-X","article-title":"Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation","volume":"52","author":"Kramer","year":"1996","journal-title":"Biochemical Pharmacology"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009002408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009002408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T05:44:25Z","timestamp":1558244665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009002408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0021915009002408"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.03.029","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}